Literature DB >> 8931219

Increase in portal blood interleukin-6 soon after the commencement of digestive surgery.

T Maeba1, H Maeta, H Usuki, H Wakabayashi, T Tsubouchi, S Okada, T Takeda, I Hamamoto, K Okano, K Ishimura.   

Abstract

To determine whether cytokines produced in the operative field during digestive surgery selectively spill over into the portal blood, the changes in interleukin-6 (IL-6) levels in portal and peripheral venous blood were assayed at several points in time from the commencement of surgery until 14 days later, in 11 patients. Similar changes in the IL-6 levels were observed in the portal and peripheral blood samples; however, the IL-6 levels in the portal blood reached a maximum 6-12h after the commencement of surgery, being earlier than in the peripheral venous blood. In fact, between 3 and 12h after the commencement of surgery, the IL-6 levels were higher in the portal blood by 33-81 pg/ml. By 24h or more after the commencement of surgery, the IL-6 levels did not differ significantly in the two types of blood samples. Moreover, the C-reactive protein levels 2 days after surgery were even more closely correlated to the maximum IL-6 levels in the portal blood than to those in the peripheral venous blood. These results suggest that IL-6 produced during intra-abdominal digestive surgery initially enters the portal blood, being trapped by IL-6 receptors in the liver, where it may regulate the synthesis of acute-phase proteins as a hepatocyte-stimulating factor.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8931219     DOI: 10.1007/bf00311790

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  8 in total

1.  IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNA.

Authors:  J A Elias; V Lentz
Journal:  J Immunol       Date:  1990-07-01       Impact factor: 5.422

Review 2.  Cytokines as communication signals between leukocytes and endothelial cells.

Authors:  A Mantovani; E Dejana
Journal:  Immunol Today       Date:  1989-11

3.  Elevation of serum interleukin 6 prior to acute phase proteins on the inflammation by surgical operation.

Authors:  N Nishimoto; K Yoshizaki; H Tagoh; M Monden; S Kishimoto; T Hirano; T Kishimoto
Journal:  Clin Immunol Immunopathol       Date:  1989-03

4.  Hepatocyte-stimulating factor: a monocyte-derived acute-phase regulatory protein.

Authors:  D G Ritchie; G M Fuller
Journal:  Ann N Y Acad Sci       Date:  1983-06-27       Impact factor: 5.691

5.  Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte-stimulating factor in the rat.

Authors:  J V Castell; T Geiger; V Gross; T Andus; E Walter; T Hirano; T Kishimoto; P C Heinrich
Journal:  Eur J Biochem       Date:  1988-11-01

6.  Elevation of circulating interleukin 6 after surgery: factors influencing the serum level.

Authors:  K Sakamoto; H Arakawa; S Mita; T Ishiko; S Ikei; H Egami; S Hisano; M Ogawa
Journal:  Cytokine       Date:  1994-03       Impact factor: 3.861

7.  Interleukin-6 as a new indicator of inflammatory status: detection of serum levels of interleukin-6 and C-reactive protein after surgery.

Authors:  H Ohzato; K Yoshizaki; N Nishimoto; A Ogata; H Tagoh; M Monden; M Gotoh; T Kishimoto; T Mori
Journal:  Surgery       Date:  1992-02       Impact factor: 3.982

8.  Tumor necrosis factor alpha inhibits hepatocyte mitochondrial respiration.

Authors:  J Stadler; B G Bentz; B G Harbrecht; M Di Silvio; R D Curran; T R Billiar; R A Hoffman; R L Simmons
Journal:  Ann Surg       Date:  1992-11       Impact factor: 12.969

  8 in total
  2 in total

1.  Significant changes in the serum levels of IL-6, h-HGF, and type IV collagen 7S during the perioperative period of a hepatectomy: relevance to SIRS.

Authors:  K Namekata; S Takamori; K Kojima; T Beppu; S Futagawa
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

2.  Relationship between cytokine gene polymorphisms and risk of postoperative pneumonia with esophageal cancer.

Authors:  Kazuhiko Sakamoto; Masaaki Oka; Shigehumi Yoshino; Shoichi Hazama; Shigeru Takeda; Kiyoshi Yoshimura; Naoko Okayama; Yuji Hinoda
Journal:  J Gastrointest Surg       Date:  2014-05-08       Impact factor: 3.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.